CCN1 and bronchopulmonary dysplasia: Recombinant CCN1 protein treatment exhibited an anti-inflammatory effect and attenuated hyperoxia-induced lung injury in neonatal rats [34], suggesting that CCN1 has potential utility in BPD diagnosis and development of future therapeutics.